SARS-CoV-2: Key Protein Discovery & Immune Evasion
- Scientists have pinpointed a key protein, nsp15, that helps SARS-CoV-2, the virus causing COVID-19, to proliferate and evade the body's defenses.
- The research team employed several approaches to understand nsp15's role.
- Next, the team tested the modified virus in an experimental model carrying the human receptor for SARS-CoV-2.
Scientists have identified the nsp15 protein as a critical element enabling SARS-CoV-2, responsible for COVID-19, to flourish and sidestep the body’s immune defenses. This groundbreaking discovery suggests that targeting nsp15 could lead to the progress of potent antiviral drugs. Research indicates that a modified virus lacking functional nsp15 showed significantly reduced growth and disease severity in lab models, pointing to nsp15’s key role in viral replication and immune evasion.The team’s findings open avenues for designing broad-spectrum treatments, potentially effective against present and future coronaviruses. Investigating the structural similarities of nsp15 across various coronaviruses is crucial for advancing therapeutic solutions. Stay up-to-date with the latest medical breakthroughs thanks to News Directory 3. Discover what’s next for nsp15 research and its potential in the fight against COVID-19 and related ailments.
Scientists have pinpointed a key protein, nsp15, that helps SARS-CoV-2, the virus causing COVID-19, to proliferate and evade the body’s defenses. The findings suggest that nsp15 could be a prime target for developing antiviral drugs.
The research team employed several approaches to understand nsp15’s role. They began by using human stem cell-derived lung cells, similar to those in the air sacs most affected by COVID-19.A modified virus, engineered without functional nsp15, struggled to grow in thes cells and was less effective at suppressing the cells’ natural antiviral responses, compared to the original virus.
Next, the team tested the modified virus in an experimental model carrying the human receptor for SARS-CoV-2. The unmodified virus caused severe disease, wiht a 75% mortality rate. In contrast, the modified virus resulted in milder illness and only about 30% mortality.
in a model naturally susceptible to SARS-CoV-2, those infected with the modified virus exhibited lower viral loads in their lungs and stronger immune responses compared to those infected with the unmodified virus.
“Together,these findings show that nsp15 plays a key role in helping SARS-CoV-2 grow,evade the immune system and cause serious disease,” said saeed,an investigator at Boston University’s National Emerging Infectious Diseases Laboratories. “By revealing how nsp15 works, our findings open the door to designing antiviral drugs that target this protein and block infection. Such treatments are urgently needed, especially to protect peopel with weakened immune systems, who remain at high risk for COVID-19.”
The researchers noted that nsp15, or a very similar version, is present in nearly all human coronaviruses. Due to the structural similarities among these proteins, they likely share the same function of aiding viral spread and immune evasion. This makes the SARS-CoV-2 nsp15 protein a promising target for broad-spectrum antiviral drugs, effective not only against current coronaviruses but also against future ones.
What’s next
The team is continuing to study nsp15, aiming to design potent inhibitors that could eventually become effective treatments for COVID-19 and other coronavirus-related diseases.